Tissue Regenix Group (LSE:TRX) Days Inventory: 360.68 (As of Jun. 2025) — 27% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Tissue Regenix Group Days Inventory?

Tissue Regenix Group LSE:TRX Days Inventory is 360.68 as of Jun. 2025, which is 27% above its 10-year median of 283.50. The stock has 5 warning signs investors should review.

Days Inventory is also known as Days Sales of Inventory (DSI). Tissue Regenix Group's Average Total Inventories for the six months ended in Jun. 2025 was £11.69 Mil. Tissue Regenix Group's Cost of Goods Sold for the six months ended in Jun. 2025 was £5.92 Mil. Hence, Tissue Regenix Group's Days Inventory for the six months ended in Jun. 2025 was 360.68.

The historical rank and industry rank for Tissue Regenix Group's Days Inventory or its related term are showing as below:

LSE:TRX' s Days Inventory Range Over the Past 10 Years
Min: 116.22   Med: 283.5   Max: 382.38
Current: 323.04

During the past 13 years, Tissue Regenix Group's highest Days Inventory was 382.38. The lowest was 116.22. And the median was 283.50.

LSE:TRX's Days Inventory is not ranked
in the Biotechnology industry.
Industry Median: 183.195 vs LSE:TRX: 323.04

Tissue Regenix Group's Days Inventory increased from Jun. 2024 (316.32) to Jun. 2025 (360.68). It might indicate that Tissue Regenix Group's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tissue Regenix Group's Inventory Turnover for the six months ended in Jun. 2025 was 0.51.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tissue Regenix Group's Inventory-to-Revenue for the six months ended in Jun. 2025 was 1.15.


Tissue Regenix Group  (LSE:TRX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tissue Regenix Group's Inventory Turnover for the six months ended in Jun. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tissue Regenix Group's Inventory to Revenue for the six months ended in Jun. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Tissue Regenix Group Days Inventory Related Terms


Tissue Regenix Group Days Inventory Historical Data

* Premium members only.

The historical data trend for Tissue Regenix Group's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Regenix Group Days Inventory Chart

Tissue Regenix Group Annual Data
Trend Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 312.21 311.25 273.16 296.49 295.78

Tissue Regenix Group Semi-Annual Data
Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 287.95 322.02 316.32 290.93 360.68

LSE:TRX vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, Tissue Regenix Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tissue Regenix Group Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's Days Inventory distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's Days Inventory falls into.



Tissue Regenix Group Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tissue Regenix Group's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

Days Inventory (A: Dec. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2023 ) + Total Inventories (A: Dec. 2024 )) / count ) / Cost of Goods Sold (A: Dec. 2024 )*Days in Period
=( (8.183 + 11.079) / 2 ) / 11.885*365
=9.631 / 11.885*365
=295.78

Tissue Regenix Group's Days Inventory for the quarter that ended in Jun. 2025 is calculated as:

Days Inventory (Q: Jun. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2024 ) + Total Inventories (Q: Jun. 2025 )) / count ) / Cost of Goods Sold (Q: Jun. 2025 )*Days in Period
=( (11.079 + 12.305) / 2 ) / 5.916*365 / 2
=11.692 / 5.916*365 / 2
=360.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 360.68 mean?
Tissue Regenix Group (LSE:TRX) has a Days Inventory of 360.68 as of Jun. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Tissue Regenix Group and its competitors. This is 27% above median its historical median of 283.50. Over the past decade, Tissue Regenix Group's Days Inventory has ranged from 116.22 to 382.38.
Is Tissue Regenix Group's Days Inventory too high?
Tissue Regenix Group's current Days Inventory of 360.68 is 27% above median its 10-year median of 283.50. Over the past 10 years, this metric has ranged from a low of 116.22 to a high of 382.38. The Biotechnology industry median Days Inventory is 183.20. Tissue Regenix Group's value of 360.68 is 96.9% above this industry median.
How does Tissue Regenix Group's Days Inventory compare to VRTX and REGN?
Tissue Regenix Group's Days Inventory of 360.68 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 183.20. Tissue Regenix Group's value of 360.68 is 96.9% above this benchmark. Historically, Tissue Regenix Group's own Days Inventory has ranged from 116.22 to 382.38 over the past decade. While the company's 10-year median is 283.50 vs. the industry median of 183.20, Tissue Regenix Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tissue Regenix Group's current Days Inventory of 360.68 is 96.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Tissue Regenix Group and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tissue Regenix Group's current Days Inventory is 360.68, which is 27% above median its own 10-year median of 283.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Regenix Group stock overvalued right now?
Tissue Regenix Group (LSE:TRX) has a current Days Inventory of 360.68. The stock's GF Value™ is £0.87, compared to a current price of £0.07 — trading 91.7% below its estimated fair value. The current Days Inventory is 360.68, which is 27% above median its 10-year median of 283.50 and 96.9% above the Biotechnology industry median of 183.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Tissue Regenix Group (LSE:TRX), the current Days Inventory is 360.68 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tissue Regenix Group Business Description

Address Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.